Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion type Assertion NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_head.
- NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion description "[Clinical significance of FGF3 overexpression was studied by immunohistochemistry (IHC) using an HCC tissue microarray (TMA) containing 60 pairs of primary/metastatic HCCs and 30 pairs of primary/recurrent HCCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_provenance.
- NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion evidence source_evidence_literature NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_provenance.
- NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion SIO_000772 17215076 NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_provenance.
- NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion wasDerivedFrom befree-20140225 NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_provenance.
- NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_assertion wasGeneratedBy ECO_0000203 NP641537.RAHMOF_iqWGKzQnMXWhD4yhWr1UVnW6KOoCd_Ft8xRUfQ130_provenance.